Clinical and experimental evidence indicates that circulating irisin levels are reduced under metabolic stress, including OB and T2DM, with declines correlating with insulin resistance, sarcopenia, and cognitive dysfunction [62,63]. The gene discussed is FNDC5; the disease is sarcopenia.